Hervorgehoben
JAHRESPARTNER
AKTUELLES
Pakajo holt sich 1,2 Mio. EUR für die nächste Wachstumsphase
Der digitale Versanddienstleister pakajo sichert sich 1,2 Mio. EUR in einer Pre-Series-A2-Finanzierungsrunde. Das Investment erfolgt über das Companisto Business Angel Netzwerk, worüber das Unternehmen aus Hamburg bereits zum zweiten Mal Kapital aufnimmt. Mit der...
How companies and investors can finance growth
Germany’s biotech sector combines scientific depth, experienced talent, and strong regional clusters. Yet many companies still struggle to convert research into late-stage development, market access, and scale. The issue is less a shortage of...
‘Europe needs more speed, far less bureaucracy, and more ambition’
With HMNC, Carsten Maschmeyer aims to make the treatment of depression more precise. In this interview, the founder discusses the EUR 50 million series B financing round, new clinical data, and what Europe needs...
‘What needs to catch up is the speed of translation from idea to commerce’
Crelux has grown from a structural biology company into a multidisciplinary discovery hub within WuXi AppTec. Dr Thomas Meins discusses accelerating drug discovery, helping biotech start-ups use capital efficiently, and why Europe must become...
‘We want to go from being top-class in research to being top-class competitors’
Germany has world-class health research, but turning scientific excellence into market success requires more private capital. Federal Minister of Research, Technology and Space Dorothee Bär discusses biotech, women’s health and the ‘GO-Bio next’ initiative...
Novartis eröffnet neue Niederlassung in München
Der Schweizer Pharmakonzern Novartis hat seine neue Niederlassung in München offiziell eröffnet. Im Bürogebäude "The Stack" in der Goethestraße 11 in fußläufiger Entfernung vom Münchener Hauptbahnhof bezieht das Unternehmen rund 2.600 Quadratmeter Fläche. Der...